PNC Financial Services Group’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $96.6K | Buy |
+4,828
| New | +$85.3K | ﹤0.01% | 2945 |
|
|
2026
Q1 | – | Sell |
-42
| Closed | -$705 | – | 5234 |
|
|
2025
Q4 | $705 | Sell |
42
-7,298
| -99% | -$123K | ﹤0.01% | 4768 |
|
|
2025
Q3 | $114K | Hold |
7,340
| – | – | ﹤0.01% | 2717 |
|
|
2025
Q2 | $94K | Sell |
7,340
-6,360
| -46% | -$78.4K | ﹤0.01% | 2747 |
|
|
2025
Q1 | $174K | Hold |
13,700
| – | – | ﹤0.01% | 2283 |
|
|
2024
Q4 | $180K | Hold |
13,700
| – | – | ﹤0.01% | 2293 |
|
|
2024
Q3 | $207K | Sell |
13,700
-1,702
| -11% | -$25.8K | ﹤0.01% | 2151 |
|
|
2024
Q2 | $218K | Buy |
15,402
+2,087
| +16% | +$28.2K | ﹤0.01% | 2080 |
|
|
2024
Q1 | $181K | Buy |
+13,315
| New | +$184K | ﹤0.01% | 2252 |
|
|
2023
Q3 | – | Sell |
-17
| Closed | -$230 | – | 4665 |
|
|
2023
Q2 | $230 | Hold |
17
| – | – | ﹤0.01% | 4657 |
|
|
2023
Q1 | $237 | Hold |
17
| – | – | ﹤0.01% | 4586 |
|
|
2022
Q4 | $242 | Hold |
17
| – | – | ﹤0.01% | 4620 |
|
|
2022
Q3 | $0 | Sell |
17
-1,668
| -99% | -$24.9K | ﹤0.01% | 4519 |
|
|
2022
Q2 | $24K | Sell |
1,685
-463
| -22% | -$6.99K | ﹤0.01% | 3406 |
|
|
2022
Q1 | $36K | Buy |
2,148
+500
| +30% | +$8.61K | ﹤0.01% | 3288 |
|
|
2021
Q4 | $32K | Buy |
1,648
+15
| +0.9% | +$302 | ﹤0.01% | 3340 |
|
|
2021
Q3 | $34K | Sell |
1,633
-6,806
| -81% | -$146K | ﹤0.01% | 3276 |
|
|
2021
Q2 | $181K | Buy |
8,439
+6,847
| +430% | +$138K | ﹤0.01% | 2284 |
|
|
2021
Q1 | $31K | Buy |
1,592
+13
| +0.8% | +$268 | ﹤0.01% | 3220 |
|
|
2020
Q4 | $31K | Buy |
1,579
+15
| +1% | +$277 | ﹤0.01% | 3153 |
|
|
2020
Q3 | $27K | Buy |
1,564
+12
| +0.8% | +$215 | ﹤0.01% | 3075 |
|
|
2020
Q2 | $28K | Hold |
1,552
| – | – | ﹤0.01% | 3053 |
|
|
2020
Q1 | $23K | Buy |
1,552
+19
| +1% | +$311 | ﹤0.01% | 3038 |
|
|
2019
Q4 | $27K | Buy |
1,533
+11
| +0.7% | +$181 | ﹤0.01% | 3194 |
|
|
2019
Q3 | $23K | Buy |
1,522
+14
| +0.9% | +$224 | ﹤0.01% | 3283 |
|
|
2019
Q2 | $25K | Buy |
1,508
+13
| +0.9% | +$214 | ﹤0.01% | 3256 |
|
|
2019
Q1 | $26K | Sell |
1,495
-253
| -14% | -$4.37K | ﹤0.01% | 3246 |
|
|
2018
Q4 | $26K | Buy |
1,748
+595
| +52% | +$10.5K | ﹤0.01% | 3193 |
|
|
2018
Q3 | $24K | Hold |
1,153
| – | – | ﹤0.01% | 3363 |
|
|
2018
Q2 | $21K | Sell |
1,153
-6
| -0.5% | -$113 | ﹤0.01% | 3424 |
|
|
2018
Q1 | $21K | Hold |
1,159
| – | – | ﹤0.01% | 3410 |
|
|
2017
Q4 | $22K | Sell |
1,159
-200
| -15% | -$4K | ﹤0.01% | 3360 |
|
|
2017
Q3 | $29K | Hold |
1,359
| – | – | ﹤0.01% | 3189 |
|
|
2017
Q2 | $29K | Hold |
1,359
| – | – | ﹤0.01% | 3170 |
|
|
2017
Q1 | $26K | Hold |
1,359
| – | – | ﹤0.01% | 3176 |
|
|
2016
Q4 | $23K | Sell |
1,359
-400
| -23% | -$7.02K | ﹤0.01% | 3173 |
|
|
2016
Q3 | $32K | Sell |
1,759
-150
| -8% | -$2.83K | ﹤0.01% | 3019 |
|
|
2016
Q2 | $33K | Sell |
1,909
-1,193
| -38% | -$22K | ﹤0.01% | 3029 |
|
|
2016
Q1 | $56K | Sell |
3,102
-1,431
| -32% | -$26K | ﹤0.01% | 2768 |
|
|
2015
Q4 | $106K | Sell |
4,533
-319
| -7% | -$7.91K | ﹤0.01% | 2417 |
|
|
2015
Q3 | $109K | Hold |
4,852
| – | – | ﹤0.01% | 2470 |
|
|
2015
Q2 | $136K | Sell |
4,852
-1,300
| -21% | -$36K | ﹤0.01% | 2461 |
|
|
2015
Q1 | $169K | Sell |
6,152
-1,505
| -20% | -$41K | ﹤0.01% | 2350 |
|
|
2014
Q4 | $191K | Sell |
7,657
-872
| -10% | -$20.9K | ﹤0.01% | 2102 |
|
|
2014
Q3 | $188K | Hold |
8,529
| – | – | ﹤0.01% | 2023 |
|
|
2014
Q2 | $177K | Hold |
8,529
| – | – | ﹤0.01% | 1984 |
|
|
2014
Q1 | $186K | Buy |
8,529
+17
| +0.2% | +$378 | ﹤0.01% | 1927 |
|
|
2013
Q4 | $174K | Buy |
8,512
+892
| +12% | +$17.3K | ﹤0.01% | 1938 |
|
|
2013
Q3 | $147K | Hold |
7,620
| – | – | ﹤0.01% | 1984 |
|
|
2013
Q2 | $136K | Buy |
+7,620
| New | +$138K | ﹤0.01% | 1950 |
|
Other funds holding HQL
FHA
1WA
FAM
BBPWM
UPS
ZCP
SI
PNC Financial Services Group's HQL Position: Q2 2026 in Review
PNC Financial Services Group opened a new position in abrdn Life Sciences Investors (HQL) in Q2 2026: 4,828 shares worth $96.6K. The stake represents ﹤0.01% of the portfolio and ranks #2945 among its holdings. This is a return to the name: PNC Financial Services Group previously reported a position in HQL as recently as Q4 2025.
PNC Financial Services Group first reported a position in HQL in Q2 2013 and has held it in 50 quarters since. The position peaked at $218K in Q2 2024. 45 funds tracked by Wall St. Rank hold HQL as of Q2 2026.
- PNC Financial Services Group held 4,828 shares of abrdn Life Sciences Investors worth $96.6K as of Q2 2026.
- abrdn Life Sciences Investors was a new PNC Financial Services Group position in Q2 2026.
- abrdn Life Sciences Investors made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2945 holding.
- PNC Financial Services Group first reported a position in abrdn Life Sciences Investors in Q2 2013 and has held it in 50 quarters since.
- PNC Financial Services Group's abrdn Life Sciences Investors position peaked at $218K in Q2 2024.
- 45 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.